QIF-T0074
criticalCognitive inference from longitudinal in-ear EEG (personalized cognitive profiling)
Tier 4 — Demonstrated (Case Study / Observational)
Legacy status: EMERGING
Given continuous in-ear EEG from QIF-T0073, an ML pipeline trained on the target's neural data over days-to-weeks builds a personalized cognitive profile. Phase 1: baseline extraction (resting alpha power, theta/beta ratio, individual alpha frequency). Phase 2: event-related feature learning (P300 amplitude to stimuli, N400 to semantic content, auditory steady-state responses). Phase 3: longitudinal pattern recognition (attention cycles, emotional valence responses, fatigue signatures, cognitive load indicators). Phase 4: adaptive exploitation — the attacker can now predict the target's cognitive state in real-time and optimize content delivery (ads, misinformation, persuasion) to moments of maximal susceptibility (high theta/low beta = low vigilance, elevated P300 = high attention to specific content). This is the cognitive analog of behavioral advertising but operating on neural signals rather than click patterns. Foundation models for EEG (BENDR, LaBraM) make transfer learning from small per-user datasets feasible. The attack chain is: QIF-T0072 (acoustic access) → QIF-T0073 (neural data capture) → QIF-T0074 (cognitive exploitation).
Technique Details
- Tactic
- QIF-S.HV
- Status
- EMERGING
- Bands
- N3, N4, N5, N6, N7, S2, S3
✚ Therapeutic Application
Machine learning model trained on longitudinal in-ear EEG data to infer cognitive states, build personalized profiles, and enable adaptive neural-targeted content manipulation
Clinical Analog
Longitudinal EEG monitoring for neurofeedback and cognitive rehabilitation
Treats
- ADHD neurofeedback training
- depression treatment monitoring (alpha asymmetry tracking)
- cognitive decline early detection (MCI/Alzheimer's)
- personalized learning optimization
Neural Impact
7 of 7 neural bands affected
Drag to rotate. Click a region to learn more.
Click or hover over a glowing region to see the attack techniques targeting it and their severity.
DSM-5-TR Diagnostic Mappings
Diagnostic category references for threat modeling, not diagnostic claims.
Pathway: N7 (PFC/M1) → executive function; N6 (hippocampus/amygdala) → emotion regulation
Following Poldrack (2006), brain region disruption does not uniquely predict psychiatric outcomes.
Scoring
NISS:1.1/BI:N/CR:H/CD:H/CV:I/RV:F/NP:T CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:L/VA:N/SC:H/SI:L/SA:N Governance
Neurorights at Risk
This technique threatens 5 of the 4 proposed neurorights (Ienca & Andorno, 2017).
FDORA §3305 Compliance
- ! CVSS cannot express neural-specific impacts
- ! No FDA pathway for consumer sensor exploitation
Population Vulnerability
CRB vulnerability adjustment (γ=0.30) accounts for age, diagnosis severity, consent capacity, and device dependency.
| Population | NISS Base | Adjusted | Severity | Delta |
|---|---|---|---|---|
| Adult (Default) | 4.0 | 4.0 | Medium | - |
| Child (10yr) + ADHD | 4.0 | 4.7 | Medium | +0.71 |
| Adult with ALS | 4.0 | 4.6 | Medium | +0.64 |
Validation Status
Theoretical / Not yet validated. This technique has not been independently tested. See the validation dashboard for what has been tested.